Reneo Pharmaceuticals
(NASDAQ:RPHM)
Reneo Pharmaceuticals, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Reneo Pharmaceuticals, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$2.77
0.01[0.36%]
At close: Aug 12
$2.70
-0.0700[-2.53%]
After Hours: 4:26PM EDT
Day High/Low2.76 - 2.89
52 Week High/Low1.92 - 9.6
Open / Close2.79 / 2.77
Float / Outstanding11.1M / 24.5M
Vol / Avg.4.4K / 101K
Mkt Cap67.8M
P/E-
50d Avg. Price2.7
Div / Yield-
Payout Ratio-
EPS-0.5
Total Float11.1M

Reneo Pharmaceuticals (NASDAQ:RPHM), Quotes and News Summary

Reneo Pharmaceuticals (NASDAQ: RPHM)

Day High/Low2.76 - 2.89
52 Week High/Low1.92 - 9.6
Open / Close2.79 / 2.77
Float / Outstanding11.1M / 24.5M
Vol / Avg.4.4K / 101K
Mkt Cap67.8M
P/E-
50d Avg. Price2.7
Div / Yield-
Payout Ratio-
EPS-0.5
Total Float11.1M
Sector: Health Care.Industry: Biotechnology
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Reneo Pharmaceuticals Questions & Answers

Q
How do I buy Reneo Pharmaceuticals (RPHM) stock?
A

You can purchase shares of Reneo Pharmaceuticals (NASDAQ: RPHM) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Reneo Pharmaceuticals's (RPHM) competitors?
Q
What is the target price for Reneo Pharmaceuticals (RPHM) stock?
A

The latest price target for Reneo Pharmaceuticals (NASDAQ: RPHM) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting RPHM to rise to within 12 months (a possible 44.40% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Reneo Pharmaceuticals (RPHM)?
A

The stock price for Reneo Pharmaceuticals (NASDAQ: RPHM) is $2.77 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Reneo Pharmaceuticals (RPHM) pay a dividend?
A

The next Reneo Pharmaceuticals (RPHM) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Reneo Pharmaceuticals (NASDAQ:RPHM) reporting earnings?
A

Reneo Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Reneo Pharmaceuticals (RPHM) going to split?
A

There is no upcoming split for Reneo Pharmaceuticals.

Q
What sector and industry does Reneo Pharmaceuticals (RPHM) operate in?
A

Reneo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.